Compare FULC & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FULC | CAL |
|---|---|---|
| Founded | 2015 | 1878 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.8M | 400.3M |
| IPO Year | 2019 | 1994 |
| Metric | FULC | CAL |
|---|---|---|
| Price | $3.64 | $13.14 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $16.38 | $15.00 |
| AVG Volume (30 Days) | ★ 4.2M | 660.5K |
| Earning Date | 04-27-2026 | 05-28-2026 |
| Dividend Yield | N/A | ★ 2.13% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | ★ $85,513,000.00 |
| Revenue This Year | N/A | $5.19 |
| Revenue Next Year | N/A | $2.45 |
| P/E Ratio | ★ N/A | $30.93 |
| Revenue Growth | N/A | ★ 0.46 |
| 52 Week Low | $2.83 | $8.80 |
| 52 Week High | $15.74 | $16.14 |
| Indicator | FULC | CAL |
|---|---|---|
| Relative Strength Index (RSI) | 32.75 | 48.03 |
| Support Level | $2.83 | $11.85 |
| Resistance Level | $8.18 | $13.97 |
| Average True Range (ATR) | 0.27 | 1.01 |
| MACD | 0.02 | -0.15 |
| Stochastic Oscillator | 20.76 | 33.83 |
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.